drug designing- jaideep sarkar

Upload: jaideep-sarkar

Post on 06-Apr-2018

227 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    1/25

    A

    H G

    B

    C

    D

    E

    F

    Drug Design(DOCKING)

    R

    P

    By:

    JAIDEEP SARKAR

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    2/25

    High Throughput Screeningp104 ligands per day

    Drug Des ign

    But: Hit Rate 10-6 per ligand

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    3/25

    RATIONAL DRUG D E S I GN

    Compound

    databases,

    Microbial broths,

    Plants extracts,

    Combinatorial

    Libraries

    3-D ligand

    Databases

    Docking

    Linking or

    Binding

    Receptor-Ligand

    Complex

    Random

    screening

    synthesis

    Lead molecule

    3-D QSAR

    Target Enzyme

    OR Receptor

    3-D structure by

    Crystallography,NMR, electron

    microscopy OR

    Homology Modeling

    Redesign

    to improve

    affinity,

    specificity etc.

    Testing

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    4/25

    Structure specific drugs

    Act at specific sites (receptor or enzyme)-Activity/potency susceptible to small changes in

    structure

    Ex.- It took Pfizer about 18 years to develop the anti-inflammatory drug Piroxicam, which

    was launched in 1980 during the golden age of rational drug discovery

    MECHANISM OF DRUGACTION

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    5/25

    Substrate

    Protein

    Ligand

    BINDING

    REACTION

    FUNCTION

    STRUCTURAL

    CHANGE

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    6/25

    What is Docking?

    Docking attempts to find the best matching between two molecules

    It includes finding the Right Key for the Lock

    Given two biological molecules determine:

    - Whether the two molecules interact

    - If so, what is the orientation that maximizes the interaction

    while minimizing the total energy of the complex

    Goal: To be able to search a database of molecular structures

    and retrieve all molecules that can interact with the query

    structure

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    7/25

    The Process

    Identify disease

    protein Identify active siteDetermine structure

    of Protein

    Virtual Screening of

    Drug Candidates

    Synthesis of Lead

    Compounds

    Pharmacological

    Testing

    Optimisation Clinical Trials Drug

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    8/25

    D o c k i n g P r o t o c o l

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    9/25

    c o n t d . . .

    RANDOM START POSITION:

    Creation of a decoy begins with a random orientation of

    each partner and a translation of one partner along the line

    of protein centers to create a glancing contact between the

    proteins

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    10/25

    Lead Op t imiza t ion

    Lead Lead OptimizationActive site

    Express proteins

    with changes in

    amino acid

    sequences

    Identify amino

    acids involved infunction

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    11/25

    Generate molecular surface of protein

    Cavities in the receptor are used to

    define spheres (blue); the centres

    are potential locations for ligand atoms.

    Sphere centres are matched to ligand

    atoms, to determine possible orientations

    for the ligand. 104 orientations generated

    How DOCK works.

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    12/25

    Virtual screening, toidentify potential leadcompounds from a large

    dataset Known structures of organic

    compounds

    Libraries of Virtual Compounds

    Programs calculate affinity forprotein

    Narrow down to small number of

    possiblities

    Surfacerepresentation thatefficiently represents the docking

    surface and identifies the regions of

    interest (cavities and protrusions)

    Surface matching that matches

    surfaces to optimize a binding score

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    13/25

    Poseprediction

    If we know exactly

    where and how aknown ligand binds...

    We can see which

    parts are importantfor binding

    We can suggest

    changes to improve

    affinity

    Avoid changes that

    will clash with the

    protein

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    14/25

    Monte Carlo methods (MC)

    Molecular Dynamics (MD)

    Simulated Annealing (SA)

    Genetic Algorithms (GA)

    Available in packages:

    Auto Dock (MC,GA,SA)

    GOLD (GA)

    Sybyl (MD)

    Rosetta DOCK (Baker ,

    Washington Univ., Gray,

    Johns Hopkins Univ.)

    Introducing flexibility:

    Whole molecule docking programs

    Glide (Schrodinger)

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    15/25

    Why is docking important?

    It is the key to rational drug design: The results of

    docking can be used to find inhibitors for specific

    target proteins and thus to design new drugs. It isgaining importance as the number of proteins

    whose structure is known increases

    In addition to new drug discovery, it is of extreme

    relevance in cellular biology, where function isaccomplished by proteins interacting with

    themselves and with other molecular components

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    16/25

    M o d i f i e d Simple A l g o r i t h m a n d 3D

    Superposi t ion and A l ignment

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    17/25

    Drug Discovery by Drug Designing

    Case Study: Tuberculosis

    Crystals &

    Crystal structure

    Lead compound

    Virtual Screening

    Combinatorial chemistryEnzyme assay

    -0.006 -0.004 -0.002 0 0.002 0.004 0.006 0.008 0.010 0.012 0.014-1

    0

    1

    2

    3

    4

    5

    6

    7AccD5-NCI65828

    1/[Malonyl-CoA]um-1

    1/Vo(min-1

    )

    [I] = 0.00

    [I] = 2.50

    [I] = 5.00

    [I] =10.00

    TB ACCase,AccD5

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    18/25

    Docking

    The Computational Loop -

    Similarity Search

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    19/25

    Structure-Based Drug Design

    Identified AccD5 Inhibitors

    New TB drug lead

    HO3S

    NH2

    N

    N

    OH

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    20/25

    Why i s th i s d i f f i cu l t? Both molecules are flexible and may alter each others

    structure as they interact:

    Hundreds to thousands of degrees of freedom (DOF)

    Total possible conformations are astronomical

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    21/25

    Trypsinogen

    Trypsin

    Chymotrypsinogen

    Chymotrypsin

    Duodenal Cell

    Enterokinase

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    22/25

    USES OF DOCKING

    Drug targets Protein- ligand interactions that otherwise may be

    overlooked

    Better understand the Machinery ofLife

    Enzyme-inhibitor class

    Antibody-antigen class

    Others

    Protein Therapies

    Engineered Protein Enzymes Although the reliability of docking methods is not so

    high, they can provide new suggestions

    False positives rates can be reduced using several scoring

    functions in a consensus-scoring strategy

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    23/25

    Large tomatoes can evolve from wild,blueberry-size tomatoes. The genetic

    mechanism responsible for this is

    similar to the one that proliferates

    cancer cells in mammalians. That's a

    connection nobody could have made

    in the past.

    Cancer cell growth appears to be related to

    evolutionary development of plump fruits and

    vegetables

    ADVANCE USE.

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    24/25

    Future Challenges For Docking

    Better Scoring Functions

    High-Throughput Screening

    Tractable Models ofFlexibility

    The so-called computational molecular docking problem is farfrom being solved. There are two major bottle-necks:

    1. The algorithms can handle only a limited extent of

    backbone flexibility2. The availability of selective and efficient scoring

    functions

  • 8/3/2019 Drug Designing- JAIDEEP SARKAR

    25/25